Safia K. Rizvi, PhD, MBA

Dr. Rizvi is a multilingual biopharma business executive and entrepreneur with 20+ years of experience in all aspects of BioPharma value chain, from drug discovery to commercialization. She leverages science and business expertise to enhance pipeline, accelerate regulatory approval, and optimize reimbursement to create value for biopharma. She is highly skilled at transitioning scientific concepts into pipeline, and research into successfully commercialized products. 


She founded Cila Therapeutics and defines vision and strategy and manages day-to-day activities. Dr. Rizvi is a decisive leader who effectively blends rigorous analytical skills with a natural leadership style grounded in competence, integrity, and humility.